Hybrid Pharma LLC
483 response sent January 31, 2024 · Florida
- Pages
- 4
- FEI number
- 3011319445
In short: This is Hybrid Pharma LLC's written response to FDA, dated January 31, 2024, for its site in Florida (FEI 3011319445). It sets out the corrective actions the firm committed to.
Inside this response
This inspection in context
Questions about this response
When was Hybrid Pharma LLC inspected by FDA?
This 483 response is dated January 31, 2024.
How do I get the full 483 response for Hybrid Pharma LLC?
Download the original PDF from FDA Intel for $199, with no subscription. You also get an invoice PDF with the order.